Industry Reports

PharmaMar forays into an exclusive licensing agreement with Seattle Genetics ensuring access to certain PharmaMar proprietary molecules for the development and commercialization of…
Read More...

Ace RNA medicines company, Arcturus Therapeutics asserted the appointment of Dr. Christine Esau, Senior Director of Translational Research, as Vice President of Research and…
Read More...

Charles River Laboratories International declared that it has ventured into a definitive agreement to obtain MPI Research for $800 million in cash. James C. Foster, Chairman and…
Read More...

Leading provider of nonclinical contract research services and research models, Envigo asserted the appointment of Lynn Lewis to the position of  Senior Vice President, Global Sales.…
Read More...

U.S Food and Drug Administration paved way for the marketing of the Viz.AI Contact application which is a type of clinical decision support software designed to interpret computed…
Read More...

Leading clinical trial technology and specialty services provider, Bracket declared the appointment of Michael Nolte as the company's Chief Executive Officer. Michael Nolte served as…
Read More...

Cytobank and the U.S Food and Drug Administration collaborate to develop machine learning-based methods for characterizing the morphology of multipotent mesenchymal stromal cells…
Read More...

Biopharmaceutical company MOLOGEN AG declared having signed a license deal for the Chinese territory and a global co-development agreement between MOLOGEN and ONCOLOGIE Inc. for its…
Read More...

Teva Pharmaceutical announced the launch of generic version of Syprine (trientine hydrochloride) capsules, 250 mg, in the U.S. Trientine hydrochloride is used in the treatment of…
Read More...

Circassia Pharmaceuticals announces that it has received a multi-year Innovative Technology contract for its NIOX VERO asthma management products from Vizient, Inc., the largest…
Read More...

Rexahn Pharmaceuticals announced that it has entered into a collaboration and license agreement with Zhejiang Haichang Biotechnology Co., Ltd. (Haichang), to develop RX-0201 (Archexin®)…
Read More...

Certara announced that it has acquired BaseCase Management GmbH, a data visualization software as a service (SaaS) company headquartered in Berlin, Germany, with offices in New York.…
Read More...

Selvita S.A. (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines for oncology patients and drug discovery services, announced the…
Read More...

Roivant Sciences and ArQule announced the initiation of a collaboration to pursue the development of derazantinib, a pan-FGFR (fibroblast growth factor receptor) inhibitor, in Greater…
Read More...

NetVation DL Medicine announced that it has entered into a two-year research collaboration with Pfizer Inc (NYSE: PFE). Under the terms of the agreement, DL Medicine will screen and…
Read More...

Liquidia Technologies announced the appointment of Kevin Gordon as President and Chief Financial Officer. Mr. Gordon will oversee finance operations and strategy, corporate development…
Read More...

Allergan plc announced that Matthew M. Walsh has been appointed Executive Vice President and Chief Financial Officer. He will formally join Allergan later this month following a…
Read More...

International contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, Cobra Biologics and Symbiosis Pharmaceutical Services asserted having clinched…
Read More...

Anika Therapeutics integrated orthopedic medicines company based on its proprietary hyaluronic acid ("HA") technology, today announced an agreement with the Institute of Integrative…
Read More...

Biopharmaceutical company focused on developing Western drug candidates in China and North Asia, CANbridge Life Sciences undertakes licensing agreement to develop and commercialize…
Read More...